↓ Skip to main content

Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial

Overview of attention for article published in Osteoporosis International, July 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
92 Mendeley
Title
Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial
Published in
Osteoporosis International, July 2014
DOI 10.1007/s00198-014-2796-0
Pubmed ID
Authors

N. Binkley, H. Bone, J. P. Gilligan, D. S. Krause

Abstract

The effect of an investigational oral calcitonin tablet upon bone mineral density (BMD) of the spine was investigated in postmenopausal women with low bone mass and at increased risk of fracture. Compared to placebo, calcitonin tablets increased lumbar spine BMD. This agent may provide an additional choice for patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 1 1%
Unknown 91 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 16%
Researcher 13 14%
Student > Ph. D. Student 12 13%
Student > Bachelor 12 13%
Student > Doctoral Student 6 7%
Other 9 10%
Unknown 25 27%
Readers by discipline Count As %
Medicine and Dentistry 26 28%
Nursing and Health Professions 10 11%
Agricultural and Biological Sciences 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 11 12%
Unknown 29 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 November 2015.
All research outputs
#14,198,017
of 22,758,963 outputs
Outputs from Osteoporosis International
#2,119
of 3,603 outputs
Outputs of similar age
#118,014
of 226,891 outputs
Outputs of similar age from Osteoporosis International
#28
of 76 outputs
Altmetric has tracked 22,758,963 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,603 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,891 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.